This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Amgen Inc., Baylor College of Medicine. Active years: 2003-2007.
Location History:
- Camarillo, CA (US) (2003)
- Ventura, CA (US) (2005 - 2007)
Company Filing History:
3 out of 2,067 
1 out of 615 
Years Active: 2003-2007
Title: The Innovations of Frederick A. Fletcher
Introduction
Frederick A. Fletcher is a notable inventor based in Ventura, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of phosphatases and their role in activating MAP kinase pathways. With a total of 3 patents to his name, Fletcher's work has implications for the diagnosis and treatment of various diseases.
Latest Patents
Fletcher's latest patents focus on novel JNK activating phosphatase polypeptides and the nucleic acid molecules that encode them. These inventions provide vectors, host cells, antibodies, and methods for producing JNK activating phosphatase polypeptides. Additionally, they offer methods for diagnosing and treating diseases associated with these polypeptides. The innovative nature of his work highlights the potential for advancements in therapeutic applications.
Career Highlights
Throughout his career, Frederick A. Fletcher has worked with prominent organizations such as Amgen Inc. and Baylor College of Medicine. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to biotechnology.
Collaborations
Fletcher has collaborated with notable colleagues, including Tse-Hua Tan and Roland Jurecic. These partnerships have played a crucial role in the development of his innovative patents and research.
Conclusion
Frederick A. Fletcher's work exemplifies the impact of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.